ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

SAN Sanofi

91.23
-0.39 (-0.43%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Sanofi SAN 유로넥스트 (Euronext) 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.39 -0.43% 91.23 00:40:00
개장가 저가 고가 종가 전일 종가
91.38 89.63 91.72 91.23 91.62
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202414:30GLOBECommuniqué de presse : Sanofi réitère ses objectifs..
23/04/202414:00GLOBECommuniqué de presse : L’étude de phase III LUNA 3 du..
17/04/202414:00GLOBECommuniqué de presse : De nouveaux résultats de phase II à..
13/04/202403:05GLOBESanofi: Informations relatives au nombre de droits de vote..
09/04/202401:00GLOBESanofi - AGM 30.04.2024 - Availability of Preparatory..
22/03/202415:30GLOBECommuniqué de presse : Mise en ligne du document «Q1 2024..
16/03/202404:04GLOBESanofi: Informations relatives au nombre de droits de vote..
11/03/202415:00GLOBEPress Release: New Phase 2b results for amlitelimab support..
24/02/202423:51GLOBEPress Release: Phase 2 results demonstrate rilzabrutinib..
24/02/202402:45GLOBECommuniqué de presse : Dépôt du Document d’Enregistrement..
23/02/202415:00GLOBEPress Release: Dupixent® sBLA accepted for FDA Priority..
23/02/202403:02GLOBECommuniqué de presse : Le Conseil d’administration de Sanofi..
21/02/202407:40GLOBESanofi: Informations relatives au nombre de droits de vote..
16/02/202415:00GLOBECommuniqué de presse : Le Japon est le premier pays dans le..
15/02/202422:00GLOBECommuniqué de presse : Des données de phase II publiées dans..
05/02/202416:00GLOBECommuniqué de presse : Entraide, conditions de travail..
01/02/202415:30GLOBECommunique de presse - 2023 : Croissance des ventes et du..
26/01/202404:30GLOBECommuniqué de presse : Dupixent® : premier et seul..
23/01/202420:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
23/01/202415:30GLOBEPress Release: Sanofi to acquire Inhibrx, Inc., adding..
18/01/202406:57GLOBESanofi: Informations relatives au nombre de droits de vote..
09/01/202416:14DJNSanofi Names Brian Foard Head of Specialty-Care Unit
09/01/202415:30GLOBECommuniqué de presse : Brian Foard est nommé Responsable de..
21/12/202316:25DJNSanofi Ends Drug Program After Late-Stage Trial in Lung..
21/12/202315:30GLOBEPress Release: Sanofi announces end of program evaluating..
19/12/202321:28DJNInnate Pharma Shares Rise after Sanofi Exercises Licensing..
19/12/202305:59GLOBESanofi: Information concerning the total number of voting..
15/12/202315:30GLOBECommuniqué de presse : Mise en ligne du document «Q4 2023..
15/12/202315:00GLOBEPress Release: EMA gives positive opinion to Fexinidazole..
12/12/202307:18DJNSanofi Terminates Agreement with Maze Therapeutics Following..
12/12/202306:08GLOBEPress Release: Statement on FTC challenge to proposed..
11/12/202315:50DJNSanofi Sees Improvement in Trial Results of Cancer Drug..
11/12/202309:30GLOBECP : Sarclisa® (isatuximab) plus KRd améliore..
07/12/202316:34DJNSanofi Myeloma Drug Sarclisa Met Primary Goal in Late-Stage..
07/12/202316:20DJNSanofi Sees Annual Sales From New Pharma Assets Above $10.8..
07/12/202315:35GLOBECP : L’essai de phase III consacré au Sarclisa® (isatuximab)..
07/12/202311:30GLOBECommuniqué de presse : Sanofi sur la voie du leadership..
06/12/202322:20DJNTrending: Merck's Multiple Sclerosis Drug Misses..
06/12/202319:14DJNMerck Shares Slump After Multiple Sclerosis Drug Fails in..
30/11/202323:23DJNTeva Closes Collaboration Deal With Sanofi on IBD Treatment
28/11/202300:31DJNTrending: Sanofi's Notus Trial Meets Primary Endpoint
27/11/202316:40DJNSanofi Says Notus Phase 3 Trial of Dupixent Met Primary..
27/11/202315:30GLOBECommuniqué de presse : Dupixent® a permis de réduire..
24/11/202302:00GLOBESanofi: Informations relatives au nombre de droits de vote..
07/11/202322:56DJNSanofi Under Preliminary Probe in France Over Possible..
30/10/202321:14DJNMeiraGTx Gets $30 Million Investment From Sanofi
28/10/202300:47DJNSanofi Down Over 19%, on Pace for Record Percent Decrease --..
27/10/202317:43DJNSanofi Shares Tumble After Warning of Profit Hit From..
27/10/202315:54DJNSanofi Backs Guidance After Earnings, Sales Miss Views
27/10/202315:35DJNSanofi Plans to Split Consumer-Healthcare, Pharma Businesses..

최근 히스토리

Delayed Upgrade Clock